Objective To study the drug resistance of extended-spectrum beta-lactamases(ESBLs)-producing Escherichia coli to aminoglycosides and the expression frequencies and sequences of drug resistant genes in Jiangchuan District,Yuxi City,Yunnan Province. Methods The drug resistance of 32 isolates of ESBLs-producing Escherichia coli to gentamycin,amikacin,kanamycin,tobramycin and netilmicin was determined by disk diffusion test. A total of 7 aminoglycoside-modifying enzyme(AME) genes [aac(3)-Ⅰ,aac(3)-Ⅱ,aac(6′)-Ⅰad,aac(6′)-Ⅰb,aac(6′)-Ⅱ,ant(3″)-Ⅰ and ant(2″)-Ⅰ] and 6 genes of 16S rRNA methylases(armA,rmtA,rmtB,rmtC,rmtD and npmA) were determined by polymerase chain reaction(PCR),and the sequence of aac(3)-Ⅱ gene was analyzed by double deoxidizing terminal cessation method. Results The drug resistant rates of 32 isolates of ESBLs-producing Escherichia coli to gentamycin,amikacin,netilmicin,kanamycin and tobramycin were 100%,0%,0%,18% and 87%,respectively. It was found that 2 AME genes existed simultaneously in 6 isolates. The positive rates of 4 AME genes,aac(3)-Ⅱ,aac(6′)-Ⅰb,ant(3″)-Ⅰ and ant(2″)-Ⅰ,were 100%,9.4%,6.2% and 3.1% in 32 isolates. There was no gene of 16S rRNA methylases. The aac(3)-Ⅱ mutations existed in 4 out of 32 isolates,which were G232A,T251C,G580A and T612A,respectively. There was no gene of AME and 16S rRNA methylases in 8 isolates of ESBLs-producing Escherichia coli. Conclusions The drug resistance of ESBLs-producingEscherichia coli to aminoglycosides was correlated with AME gene expressions,and the mutations of aac(3)-Ⅱ may contribute to the increased drug resistance to netilmicin.